BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34452091)

  • 1. Pheophorbide A and Paclitaxel Bioresponsive Nanoparticles as Double-Punch Platform for Cancer Therapy.
    Moret F; Menilli L; Battan M; Tedesco D; Columbaro M; Guerrini A; Avancini G; Ferroni C; Varchi G
    Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox- and light-responsive alginate nanoparticles as effective drug carriers for combinational anticancer therapy.
    Zhang C; Shi G; Zhang J; Niu J; Huang P; Wang Z; Wang Y; Wang W; Li C; Kong D
    Nanoscale; 2017 Mar; 9(9):3304-3314. PubMed ID: 28225139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice.
    Oh IH; Min HS; Li L; Tran TH; Lee YK; Kwon IC; Choi K; Kim K; Huh KM
    Biomaterials; 2013 Sep; 34(27):6454-63. PubMed ID: 23755832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active-targeted pH-responsive albumin-photosensitizer conjugate nanoparticles as theranostic agents.
    Battogtokh G; Ko YT
    J Mater Chem B; 2015 Dec; 3(48):9349-9359. PubMed ID: 32262934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy.
    Zhang C; Zhang J; Shi G; Song H; Shi S; Zhang X; Huang P; Wang Z; Wang W; Wang C; Kong D; Li C
    Mol Pharm; 2017 May; 14(5):1760-1770. PubMed ID: 28296410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioreducible branched polyethyleneimine derivatives physically loaded with hydrophobic pheophorbide A: preparation, characterization, and light-induced cytotoxicity.
    Cho H; Li L; Bae YH; Huh KM; Kang HC
    Macromol Biosci; 2014 Oct; 14(10):1483-94. PubMed ID: 25130538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
    Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
    Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial-targeted photosensitizer-loaded folate-albumin nanoparticle for photodynamic therapy of cancer.
    Battogtokh G; Ko YT
    Nanomedicine; 2017 Feb; 13(2):733-743. PubMed ID: 27815176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and pheophorbide A by pluronic F127 micelles for chemo-photodynamic combination therapy of melanoma.
    Zhang C; Zhang J; Qin Y; Song H; Huang P; Wang W; Wang C; Li C; Wang Y; Kong D
    J Mater Chem B; 2018 May; 6(20):3305-3314. PubMed ID: 32254388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graphene oxide-incorporated pH-responsive folate-albumin-photosensitizer nanocomplex as image-guided dual therapeutics.
    Battogtokh G; Ko YT
    J Control Release; 2016 Jul; 234():10-20. PubMed ID: 27164545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
    Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
    Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.
    Lv Y; Xu C; Zhao X; Lin C; Yang X; Xin X; Zhang L; Qin C; Han X; Yang L; He W; Yin L
    ACS Nano; 2018 Feb; 12(2):1519-1536. PubMed ID: 29350904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemo-Photothermal Combination Cancer Therapy with ROS Scavenging, Extracellular Matrix Depletion, and Tumor Immune Activation by Telmisartan and Diselenide-Paclitaxel Prodrug Loaded Nanoparticles.
    Fang T; Zhang J; Zuo T; Wu G; Xu Y; Yang Y; Yang J; Shen Q
    ACS Appl Mater Interfaces; 2020 Jul; 12(28):31292-31308. PubMed ID: 32551473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.
    Hou H; Zhang D; Lin J; Zhang Y; Li C; Wang Z; Ren J; Yao M; Wong KH; Wang Y
    J Agric Food Chem; 2018 Nov; 66(44):11812-11822. PubMed ID: 30339011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction-sensitive Paclitaxel Prodrug Self-assembled Nanoparticles with Tetrandrine Effectively Promote Synergistic Therapy Against Drug-sensitive and Multidrug-resistant Breast Cancer.
    Jiang M; Zhang R; Wang Y; Jing W; Liu Y; Ma Y; Sun B; Wang M; Chen P; Liu H; He Z
    Mol Pharm; 2017 Nov; 14(11):3628-3635. PubMed ID: 28895735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresponsive functional nanogels as an emerging platform for cancer therapy.
    Huang D; Qian H; Qiao H; Chen W; Feijen J; Zhong Z
    Expert Opin Drug Deliv; 2018 Jul; 15(7):703-716. PubMed ID: 29976103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheophorbide A and SN38 conjugated hyaluronan nanoparticles for photodynamic- and cascadic chemotherapy of cancer stem-like ovarian cancer.
    Lee J; Davaa E; Jiang Y; Shin KJ; Kim MH; An H; Kim J; Cho SK; Yang SG
    Carbohydr Polym; 2022 Aug; 289():119455. PubMed ID: 35483857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 19. Light-Activatable Red Blood Cell Membrane-Camouflaged Dimeric Prodrug Nanoparticles for Synergistic Photodynamic/Chemotherapy.
    Pei Q; Hu X; Zheng X; Liu S; Li Y; Jing X; Xie Z
    ACS Nano; 2018 Feb; 12(2):1630-1641. PubMed ID: 29346736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy.
    Li Y; Hou H; Zhang P; Zhang Z
    Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.